Generative artificial intelligence (GenAI) is opening the door for more researchers to conduct consumer studies than ever ...

Design, offers an AI agent for businesses that turns your ideas into a complete brand identity, from logos and brand kits to ...

See how ZX Series Interactive Displays bring AI, collaboration, and Google-ready tools into classrooms, helping teachers ...

Scott DeSalvo built this AI case evaluation tool himself using 28 years of experience — and personally reviews every ...

PURE: How 100% Kotton Is Redefining the Sound of Luxury House Music Miami, United States – March 30, 2026 / Kotton Grammer / ​​ FOR IMMEDIATE RELEASE Media Contact: Kotton Grammer / 100% Kotton Email: ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...

Semaglutide is part of a group of medicines called GLP-1 receptor agonists, commonly used to manage type 2 diabetes. In recent years, it has also gained worldwide attention for helping with weight ...

The FDA has approved a generic version of fluticasone propionate (marketed as Flovent HFA), according to a statement issued on March 3. The approval extends the accessibility of the medication, ...

I open my emails to find yet another message from a patient about their amphetamine-dextroamphetamine (the generic form of Aderall) no longer working. Dr. Plutchik, my meds no longer seem to be ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...